Movember is all about raising awareness of men’s health issues, including prostate cancer – one of the most common cancers to affect men. Take action this Movember by learning the risk factors and early signs and symptoms of prostate cancer. #Movember #ProstateCancer
Ferring Pharmaceuticals
Arzneimittelherstellung
70 years of building families and helping people live better lives. Guidelines: re.ferring.com/social-guidelines
Info
Ferring Pharmaceuticals is a privately owned, research-driven, specialty biopharmaceutical group committed to building families and helping people live better lives. We are leaders in reproductive medicine and maternal health, and in areas of gastroenterology and urology. We are at the forefront of innovation in microbiome-based therapeutics and uro-oncology intravesical gene therapy. Ferring was founded in 1950 and employs more than 7,000 people worldwide. The company is headquartered in Saint-Prex, Switzerland, and has operating subsidiaries in more than 50 countries which markets its medicines in over 100 countries. Community guidelines available here: https://re.ferring.com/Ferring-LinkedIn-Community-Guidelines Social Media Privacy Notice available here: https://www.ferring.com/social-media-privacy-notice/
- Website
-
http://www.ferring.com
Externer Link zu Ferring Pharmaceuticals
- Branche
- Arzneimittelherstellung
- Größe
- 5.001–10.000 Beschäftigte
- Hauptsitz
- St-Prex
- Art
- Privatunternehmen
- Gegründet
- 1950
- Spezialgebiete
- Reproductive Health, Urology, Uro-oncology, Gastroenterology, Microbiome, Endocrinology und Orthopaedics
Orte
-
Primär
-
St-Prex, 1162, CH
Beschäftigte von Ferring Pharmaceuticals
Updates
-
November is Bladder Health Month – an important time to raise awareness about bladder cancer, the 9th most common cancer worldwide. Early detection saves lives, so it's crucial to stay informed and look out for symptoms such as: • Blood in your pee • An urgent or sudden need to pee • Repeated bladder infections Today and every day, Ferring remains committed to improving the lives of those living with bladder cancer. #BladderHealthMonth #BladderCancer
-
This week marks European Fertility Week, an important time to recognise the impact of infertility and the barriers many face in accessing fertility support. Globally, 1 in 6 people are affected by infertility. Despite these high numbers, there are still several challenges which exist when it comes to accessing care - from financial constraints to inadequate support and lack of information. This is the case in Europe, and around the world. For some communities these barriers can be heightened, highlighting the need for inclusive and equitable fertility care to reduce disparities. The newly launched European Coalition for Fertility aims to address these challenges and ensure equitable access, comprehensive sex education, and family planning support for all. Here at Ferring, we share this vision and believe in a future where no one is left behind on their path to parenthood. We remain committed as ever to helping build families of every shape and size. #EuropeanFertilityWeek #FertilityAwareness #CoalitionforFertility #FertilityMatters
-
We’re thrilled to see our Chief People Officer, Christelle Beneteau, sharing Ferring’s commitment to unlocking the potential of our people. At Ferring, we believe that focusing on peoples’ strengths empowers our teams, drives growth, and supports our mission to make a meaningful difference in the lives of both our employees and patients.
I was honoured to speak at the Transforming Workplaces event held by Gallup, where I shared how we are unleashing the potential of our people for stronger business results. At Ferring, we strive to create a culture of empowerment and growth, where every team member can bring their authentic selves to work — a culture recognised by the Gallup Exceptional Workplace Award for the third consecutive year. A few weeks ago, Ferring also became the first company in Europe to be selected for the prestigious Don Clifton Strengths-Based Culture Award (Jim Clifton). By focusing on what our people do best, we help them leverage their unique talents and integrate these into their daily work. This strengths-based approach is essential to fostering employee development and engagement, advancing our organisational goals, and ultimately supporting our purpose: helping people build families and live better lives. During the Gallup event, I also had the opportunity to learn from a great panel of presenters who shared how they are transforming their own workplace, through coaching, innovative performance management approach, improving safety and building culture readiness for AI. Nalini Naidu-Sawhney, Claire Woegerbauer, Pia Metzlaff, Jeremie K Brecheisen, Sebastian Fels, Imma Catalá, Nancy Hey. #Ferring #GreatPlacetoWork #WorkPlaceCulture #EmployeeWellBeing #PeopleComeFirst
-
We are proud to announce that the CEO of Ferring Korea, Angie Kim (Minjung Kim), has been selected as a '2024 Power K-Woman' at the Women Leaders Forum hosted by The Asia Business Daily|아시아경제. This recognition is testament to her dedication to fostering a supportive and inclusive company culture at Ferring. The Women's Leadership Forum is an influential platform where female leaders from politics, business, and academia gather to share insights and experiences. During the forum, which took place this week, Minjung Kim engaged in panel discussions centred around the importance of work-life balance in creating a thriving corporate culture. Ferring’s progressive family-building benefits policy, which includes flexible working, has been instrumental in supporting employee wellbeing and enabling our team members to excel both professionally and at home. Join us in congratulating Minjung Kim on this achievement as we celebrate the progress we're making towards a more inclusive and balanced working culture. #WorkLifeBalance #BuildingFamiliesAtFerring #WomenLeadersForum2024 #WomenCorporateDirectorsKorea #MinistryofGenderEqualityandFamily
-
Join us from 4-6 November at #BIOEurope2024 - Europe’s premier partnering event for global life sciences. We look forward to connecting with industry leaders and the broader pharma and biotech community to explore how partnerships can accelerate research and drive advancements in patient care, to improve lives worldwide. Will you be attending? Please reach out to our Ferring representatives: Stanley S.H. Cheuk, Rasmus Bugge Jensen, Blanca Castell Miñón and Sue Hui Tan. For more information and to register, visit: https://lnkd.in/eCg6ZNFT. We hope to see you there! #BIOEurope #Pharma #Biotechnology #LifeSciences #Innovation #Partnerships #ReproductiveMedicine #MaternalHealth #Urology #UroOncology #Gastroenterology #Microbiome
-
We are excited to be at the 44th Annual Congress of the Société Internationale d'Urologie (SIU) in New Delhi, India, this week. As part of our commitment to addressing the unmet needs of people living with urological cancers, we are delighted to be sponsoring the 6th Bench to Bedside Uro-Oncology: GU Triad Meeting, taking place at SIU on Friday 25 October. Featuring world-renowned experts, the event will cover the latest innovations in prostate, bladder and kidney cancers. We can’t wait to connect with the wider #UroOncology community at this important scientific meeting! This post is intended for Healthcare Professionals.
-
During #BlackHistoryMonth it’s important to highlight that Black men are twice as likely to develop prostate cancer than white men. While some factors, like genetics, are beyond personal control, staying informed and being proactive about early signs and symptoms of the disease can make all the difference. #ProstateCancer #UroOncology
-
We were delighted to host more than 250 clinicians from over 40 countries at our second Fertility Exchange Event in Valencia. The two-day meeting, led by a world class steering committee of eight international experts, focused on the latest in science, technology and patient care. Great engagement from the healthcare professionals in attendance led to interesting discussions about taking fertility care to the next level. Thank you to the steering committee members Christophe Blockeel, Anja Pinborg, Georg Griesinger, Scott Nelson, Antonio La Marca, Juan A. García Velasco, Martha Luna, MD and Nathalie Massin. Thank you also to the speakers and participants, we look forward to our next Exchange Event! #ReproductiveMedicine This post is intended for healthcare professionals only.
-
We’re proud to see our Chief People Officer, Christelle Beneteau, on the A Leader Like Me podcast discussing how we foster a culture of inclusivity at Ferring. At Ferring, we believe that everyone has the right to a family and we’re committed to supporting people on their family-building journeys, no matter who they are, where they live or who they love.
I was thrilled to be invited as a guest on the A Leader Like Me podcast to discuss a topic that is so important to us at Ferring – creating a positive impact for our patients, our employees and society by fostering a culture of inclusivity. At Ferring, we are dedicated to championing inclusivity internally and externally. From our Building Families at Ferring programme, which helps potential parents across the globe on their family building journeys, to initiatives such as our partnership with Green Lamp to improve maternal health infrastructure and make childbirth safer in Ethiopia. We believe that everyone has the right to a family, and that every woman should have access to quality care and necessary treatment during pregnancy and childbirth, no matter where she lives. These efforts are something I’m truly passionate about, and I’d like to thank Advita Patel and Priya Bates, ABC, MC, SCMP, IABC Fellow for giving me a platform to share how we champion inclusivity at Ferring. https://bit.ly/4gzZJQ1 #Inclusivity #DEI #BuildingFamiliesatFerring
S4E8: Building a Culture of Inclusivity with Christelle Beneteau
podbean.com
Verbundene Seiten
Ähnliche Seiten
Finanzierung
Letzte Runde
Fremdfinanzierung530.877.573,00 $